Ident. | Authors (with country if any) | Title |
---|
000281 |
Asad Ali [Pakistan] ; RABAB ZEHRA JAFRI [Pakistan, États-Unis] ; Nancy Messonnier [États-Unis] ; Carol Tevi-Benissan [Suisse] ; David Durrheim [Australie] ; Juhani Eskola [Finlande] ; Florence Fermon [France] ; Keith P. Klugman [États-Unis, Afrique du Sud] ; Mary Ramsay [Royaume-Uni] ; Samba Sow [Mali, États-Unis] ; SHAO ZHUJUN [République populaire de Chine] ; Zulfiqar Bhutta [Pakistan] ; Jon Abramson [États-Unis] | Global practices of meningococcal vaccine use and impact on invasive disease |
000773 |
Francesca Poli [Italie] ; Sebastiaan Overeem [Pays-Bas] ; Gert Jan Lammers [Pays-Bas] ; Giuseppe Plazzi [Italie] ; Michel Lecendreux [France] ; Claudio L. Bassetti [Suisse] ; Yves Dauvilliers [France] ; Daniel Keene [Canada] ; Ramin Khatami [Suisse] ; YULIN LI [Suisse] ; Geert Mayer [Allemagne] ; Hanna Nohynek [Finlande] ; Barbara Pahud [États-Unis] ; Teresa Paiva [Portugal] ; Markku Partinen [Finlande] ; Thomas E. Scammell [États-Unis] ; Tom Shimabukuro [États-Unis] ; Miriam Sturkenboom [Pays-Bas] ; Kristy Van Dinther [Australie] ; Max Wiznitzer [États-Unis] ; Jan Bonhoeffer [Suisse] | Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation |
001F67 |
Terry M. Nolan [Australie] | The Australian model of immunization advice and vaccine funding |
004555 |
Rajesh Tim Gandhi [États-Unis] ; Marcus Altfeld [États-Unis] ; Sabine Kinloch-De Loes [Royaume-Uni] ; Bruno Hoen [France] ; Don E. Smith [Australie] ; Brigitte Autran [France] ; Fiona C. Lampe [Royaume-Uni] ; Andrew N. Phillips [Royaume-Uni] ; Li-Ean Goh [Royaume-Uni] ; Jan Andersson [Suède] ; Christos Tsoukas [Canada] ; Anders Sonnerborg [Suède] ; Giuseppe Tambussi [Italie] ; Pierre-Marie Girard [France] ; Mark Bloch [Australie] ; Manuel Battegay [Swaziland] ; Nick Carter [Royaume-Uni] ; Raphaelle El Habib [France] ; Georgia Theofan [États-Unis] ; David A. Cooper [Australie] ; Luc Perrin [Suisse] | Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. Commentary |
004D92 |
Deborah Lehmann [Papouasie-Nouvelle-Guinée, Australie] ; William S. Pomat [Papouasie-Nouvelle-Guinée, Australie] ; Ian D. Riley [Australie] ; Michael P. Alpers [Papouasie-Nouvelle-Guinée, Australie] | Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea |
005360 |
T. P. Monath [États-Unis] | Japanese encephalitis vaccines: Current vaccines and future prospects |
005492 |
A. Igarashi [Japon] | Control of Japanese encephalitis in Japan: Immunization of humans and animals, and vector control |
005740 |
Carl G. Feng [Australie] ; Umaimainthan Palendira [Australie] ; Caroline Demangel [Australie, États-Unis] ; Joanne M. Spratt [Australie] ; Adam S. Malin [France] ; Warwick J. Britton [Australie, Royaume-Uni] | Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Guerin against tuberculosis |
005A72 |
C. J. Lees [Australie] ; V. Apostolopoulos [Australie] ; B. Acres [France] ; C.-S. Ong [Australie] ; V. Popovski [Australie] ; I. F. C. Mckenzie [Australie] | The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1 |